Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ambitious plans but no cash for UK biotechnology

This article was originally published in Clinica

Executive Summary

No new funds will be made available to fund the UK government's cross-departmental "Biotechnology Crusade". The President of the Board of Trade, Ian Lang, launched the crusade, a cross-departmental drive to boost Britain's biotech industry, at the Institute of Directors, in London, last week. He said priorities include intellectual property protection and a competitive regulatory climate. The Ministers of Health, Food, Science and Technology, Agriculture, Forestry and Environment, the Scottish Office and Small Businesses all attended the launch but none had new money to support their plans.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT088310

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel